IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

Use an existing password
Company dossier

Concord Biotech

NSE:CONCORDBIO · ISIN INE338H01029

Close
Unavailable
Date unavailable
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Concord Biotech

Ratings & risks

Credit signals

Rating-action history

Agency evidence
ICRA Limited · Concord Biotech Limited: Ratings reaffirmedICRA Limited · PDF preserved by IndiaTicker
Archived PDF
ICRA Limited · Concord Biotech Limited: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Concord Biotech Limited: Ratings of [ICRA]AA-(Stable)/[ICRA]A1+ reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Concord Biotech Limited: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Concord Biotech Limited: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Concord Biotech Limited: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Concord Biotech Limited: [ICRA]AA-(Stable)/[ICRA]A1+ assigned for enhanced amountICRA Limited · discovered
Agency source
ICRA Limited · Concord Biotech Limited: [ICRA]AA-(Stable) rating assignedICRA Limited · discovered
Agency source
Risk research framework

Questions to test against evidence

Analyst review
Operating deterioration

Track sector-specific operating metrics and reconcile them across reporting periods.

High
Funding and liquidity

Review debt maturity, repricing, liquidity and rating commentary where relevant.

High
Execution versus guidance

Compare management statements with subsequent reported delivery.

Medium
Governance and key-person change

Connect management transitions, related parties and auditor observations.

Medium